| Year |
Citation |
Score |
| 2023 |
Guijarro MV, Nawab A, Dib P, Burkett S, Luo X, Feely M, Nasri E, Seifert RP, Kaye FJ, Zajac-Kaye M. TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background. Oncogene. PMID 37106126 DOI: 10.1038/s41388-023-02694-7 |
0.368 |
|
| 2023 |
Khan S, Kellish P, Connis N, Thummuri D, Wiegand J, Zhang P, Zhang X, Budamagunta V, Hua N, Yang Y, De U, Jin L, Zhang W, Zheng G, Hromas R, ... ... Kaye FJ, et al. Co-targeting BCL-X and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice. Cell Death Discovery. 9: 1. PMID 36588105 DOI: 10.1038/s41420-022-01296-8 |
0.301 |
|
| 2022 |
Khan S, Wiegand J, Zhang P, Hu W, Thummuri D, Budamagunta V, Hua N, Jin L, Allegra CJ, Kopetz SE, Zajac-Kaye M, Kaye FJ, Zheng G, Zhou D. BCL-X PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRAS-mutated cancers. Journal of Hematology & Oncology. 15: 23. PMID 35260176 DOI: 10.1186/s13045-022-01241-3 |
0.324 |
|
| 2021 |
Creelan BC, Wang C, Teer JK, Toloza EM, Yao J, Kim S, Landin AM, Mullinax JE, Saller JJ, Saltos AN, Noyes DR, Montoya LB, Curry W, Pilon-Thomas SA, Chiappori AA, ... ... Kaye FJ, et al. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nature Medicine. PMID 34385708 DOI: 10.1038/s41591-021-01462-y |
0.309 |
|
| 2021 |
Zhou X, Li JW, Chen Z, Ni W, Li X, Yang R, Shen H, Liu J, DeMayo FJ, Lu J, Kaye FJ, Wu L. Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation. Elife. 10. PMID 34142658 DOI: 10.7554/eLife.66095 |
0.391 |
|
| 2021 |
Chen Z, Ni W, Li JL, Lin S, Zhou X, Sun Y, Li JW, Leon ME, Hurtado MD, Zolotukhin S, Liu C, Lu J, Griffin JD, Kaye FJ, Wu L. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma. Jci Insight. 6. PMID 33830080 DOI: 10.1172/jci.insight.139497 |
0.338 |
|
| 2020 |
George TJ, DeRemer DL, Parekh HD, Lee J, Markham MJ, Daily KC, Kaye FJ, Staal S, Jones DV, Stechmiller BK, Allegra CJ, Hromas RA. Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma. Journal of Clinical Oncology. 38: TPS591-TPS591. DOI: 10.1200/Jco.2020.38.4_Suppl.Tps591 |
0.309 |
|
| 2020 |
ali a, DeRemer DL, Lee J, Parekh HD, Staal S, Markham MJ, Daily KC, Stechmiller BK, Jones DV, Close JL, Murphy MC, Kaye FJ, Allegra CJ, Hromas RA, George TJ. Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms (NCT03207347). Journal of Clinical Oncology. 38: e22061-e22061. DOI: 10.1200/Jco.2020.38.15_Suppl.E22061 |
0.323 |
|
| 2019 |
Stewart BD, Kaye F, Machuca T, Mehta HJ, Mohammed TL, Newsom KJ, Starostik P. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature. International Journal of Surgical Pathology. 1066896919865944. PMID 31382829 DOI: 10.1177/1066896919865944 |
0.374 |
|
| 2019 |
Tasoulas J, Rodon L, Kaye FJ, Montminy M, Amelio AL. Adaptive Transcriptional Responses by CRTC Coactivators in Cancer. Trends in Cancer. 5: 111-127. PMID 30755304 DOI: 10.1016/J.Trecan.2018.12.002 |
0.316 |
|
| 2019 |
Jiang Y, Forbes L, Li J, Freeberg S, Cao C, Zajac-Kaye M, Licht J, Kentsis A, Kaye F. Abstract 1922: MYB mimic peptides targeting human and murine MYB-NFIB positive tumor cells Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1922 |
0.35 |
|
| 2019 |
Ni W, Chen Z, Zhou X, Yang R, Kaye F, Wu L. Abstract 4837: Role of Notch signaling in human mucoepidermoid carcinoma and combined targeting of Notch and EGFR signaling as an anti-cancer strategy Cancer Research. 79: 4837-4837. DOI: 10.1158/1538-7445.Am2019-4837 |
0.365 |
|
| 2018 |
Biswas A, Jiang Y, Li D, Mehta HJ, Kaye F. The Prevalence of Rhesus-Negative Blood Group Among Patient With Small Cell Lung Cancer and Analysis of Its Effect on Overall Survival. Frontiers in Oncology. 8: 358. PMID 30250826 DOI: 10.3389/Fonc.2018.00358 |
0.324 |
|
| 2018 |
Chen Z, Lin S, Li JL, Ni W, Guo R, Lu J, Kaye FJ, Wu L. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells. Oncogene. PMID 29353885 DOI: 10.1038/S41388-017-0104-0 |
0.35 |
|
| 2017 |
Sundaresan V, Lin VT, Liang F, Kaye FJ, Kawabata-Iwakawa R, Shiraishi K, Kohno T, Yokota J, Zhou L. Significantly mutated genes and regulatory pathways in SCLC-a meta-analysis. Cancer Genetics. 216: 20-28. PMID 29025592 DOI: 10.1016/J.Cancergen.2017.05.003 |
0.307 |
|
| 2017 |
Kellish P, Shabashvili D, Rahman MM, Reinhard M, McFadden G, Kaye F, Zajac-Kaye M. Abstract 1609: Oncolytic virotherapy for SCLC using immunocompetent mouse models Cancer Research. 77: 1609-1609. DOI: 10.1158/1538-7445.Am2017-1609 |
0.418 |
|
| 2016 |
Lee HY, Mohammed KA, Goldberg EP, Kaye F, Nasreen N. Silencing Receptor EphA2 Enhanced Sensitivity to Lipoplatin™ in Lung Tumor and MPM Cells. Cancer Investigation. 1-12. PMID 27438907 DOI: 10.1080/07357907.2016.1201678 |
0.428 |
|
| 2016 |
Chen Z, Li JL, Lin S, Cao C, Gimbrone NT, Yang R, Fu DA, Carper MB, Haura EB, Schabath MB, Lu J, Amelio AL, Cress WD, Kaye FJ, Wu L. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. The Journal of Clinical Investigation. PMID 27140397 DOI: 10.1172/Jci85250 |
0.42 |
|
| 2016 |
Chen L, Engel BE, Welsh EA, Yoder SJ, Brantley SG, Chen DT, Beg AA, Cao C, Kaye FJ, Haura EB, Schabath MB, Cress WD. A sensitive NanoString-based assay to score STK11 (LKB1) pathway disruption in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26917230 DOI: 10.1016/J.Jtho.2016.02.009 |
0.31 |
|
| 2016 |
Shabashvili DE, Rahman M, Kellish P, Messer H, Reinhard M, McFadden G, Kaye F, Zajac-Kaye M. Myxomavirus (MYXV) therapy for small cell lung cancer (SCLC) using patient samples and a genetically engineered SCLC mouse model Journal of Thoracic Oncology. 11: S42-S43. DOI: 10.1016/J.Jtho.2015.12.071 |
0.327 |
|
| 2015 |
Chen Z, Li J, Lin S, Pan D, Ni W, Cao C, Gu Y, Hurtado MD, Zolotukhin S, Sun T, Kaye F, Wu L. Abstract 2284: Generation and characterization of a mouse model of CRTC1-MAML2-induced mucoepidermoid carcinoma (MEC) Cancer Research. 75: 2284-2284. DOI: 10.1158/1538-7445.Am2015-2284 |
0.491 |
|
| 2015 |
Chen Z, Li J, Lin S, Cao C, Kaye F, Wu L. Abstract 166: Identification of a novel long noncoding RNA as a mediator for CRTC1-MAML2 fusion oncogenic function and a biomarker for CRTC1-MAML2 fusion-positive tumors Cancer Research. 75: 166-166. DOI: 10.1158/1538-7445.Am2015-166 |
0.492 |
|
| 2014 |
Gao R, Cao C, Zhang M, Lopez MC, Yan Y, Chen Z, Mitani Y, Zhang L, Zajac-Kaye M, Liu B, Wu L, Renne R, Baker HV, El-Naggar A, Kaye FJ. A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets. Oncotarget. 5: 12528-42. PMID 25587024 DOI: 10.18632/ONCOTARGET.2985 |
0.359 |
|
| 2014 |
Amelio AL, Fallahi M, Schaub FX, Zhang M, Lawani MB, Alperstein AS, Southern MR, Young BM, Wu L, Zajac-Kaye M, Kaye FJ, Cleveland JL, Conkright MD. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement. Proceedings of the National Academy of Sciences of the United States of America. 111: E3260-8. PMID 25071166 DOI: 10.1073/pnas.1319176111 |
0.333 |
|
| 2014 |
Salz T, Li G, Kaye F, Zhou L, Qiu Y, Huang S. hSETD1A regulates Wnt target genes and controls tumor growth of colorectal cancer cells. Cancer Research. 74: 775-86. PMID 24247718 DOI: 10.1158/0008-5472.Can-13-1400 |
0.321 |
|
| 2014 |
Cao C, Gao R, Zhang M, Chen Z, Wu L, Kaye MZ, Kaye F. Abstract 591: LKB1 regulates COX-2 transcription via CRTCs dependent pathway Cancer Research. 74: 591-591. DOI: 10.1158/1538-7445.Am2014-591 |
0.484 |
|
| 2013 |
Sukka-Ganesh B, Mohammed KA, Kaye F, Nasreen N. Abstract 5346: MiR-331-5p targets receptor EphA2 and attenuates tumor growth and migration in NSCLC. Cancer Research. 73: 5346-5346. DOI: 10.1158/1538-7445.Am2013-5346 |
0.318 |
|
| 2013 |
Cao C, Zhang M, Gao R, Cress D, Chen Z, Wu L, Kaye MZ, Kaye F. Abstract 3105: Orphan nuclear receptor NR4A2 exhibits oncogenic activity in lung cancer cells. Cancer Research. 73: 3105-3105. DOI: 10.1158/1538-7445.Am2013-3105 |
0.51 |
|
| 2012 |
Sukka-Ganesh B, Mohammed KA, Kaye F, Goldberg EP, Nasreen N. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene. Bmc Cancer. 12: 309. PMID 22824143 DOI: 10.1186/1471-2407-12-309 |
0.459 |
|
| 2012 |
Chen M, Shabashvili D, Nawab A, Yang SX, Dyer LM, Brown KD, Hollingshead M, Hunter KW, Kaye FJ, Hochwald SN, Marquez VE, Steeg P, Zajac-Kaye M. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer. Molecular Cancer Therapeutics. 11: 370-82. PMID 22203734 DOI: 10.1158/1535-7163.Mct-11-0458 |
0.301 |
|
| 2012 |
Gu Y, Lin S, Li JL, Nakagawa H, Chen Z, Jin B, Tian L, Ucar DA, Shen H, Lu J, Hochwald SN, Kaye FJ, Wu L. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene. 31: 469-79. PMID 21706049 DOI: 10.1038/onc.2011.247 |
0.344 |
|
| 2011 |
Jaskoll T, Htet K, Abichaker G, Kaye FJ, Melnick M. CRTC1 expression during normal and abnormal salivary gland development supports a precursor cell origin for mucoepidermoid cancer. Gene Expression Patterns : Gep. 11: 57-63. PMID 20837164 DOI: 10.1016/j.gep.2010.09.003 |
0.364 |
|
| 2010 |
Chen M, Voeller D, Marquez VE, Kaye FJ, Steeg PS, Giaccone G, Zajac-Kaye M. Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. International Journal of Oncology. 37: 963-71. PMID 20811718 |
0.327 |
|
| 2010 |
Komiya T, Coxon A, Park Y, Chen WD, Zajac-Kaye M, Meltzer P, Karpova T, Kaye FJ. Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene. 29: 1672-80. PMID 20010869 DOI: 10.1038/onc.2009.453 |
0.44 |
|
| 2010 |
Park Y, Coxon A, Komiya T, Chen W, Zajac-Kaye M, Meltzer P, Karpova T, Kaye F. Abstract 1135: Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer Cancer Research. 70: 1135-1135. DOI: 10.1158/1538-7445.Am10-1135 |
0.711 |
|
| 2009 |
Kaye FJ. Mutation-associated fusion cancer genes in solid tumors. Molecular Cancer Therapeutics. 8: 1399-408. PMID 19509239 DOI: 10.1158/1535-7163.MCT-09-0135 |
0.377 |
|
| 2008 |
Park Y, Kubo A, Komiya T, Coxon A, Beebe K, Neckers L, Meltzer PS, Kaye FJ. Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras. Cell Cycle (Georgetown, Tex.). 7: 2384-91. PMID 18677112 DOI: 10.4161/Cc.6363 |
0.756 |
|
| 2007 |
Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, ... ... Kaye F, et al. High-throughput oncogene mutation profiling in human cancer. Nature Genetics. 39: 347-51. PMID 17293865 DOI: 10.1038/Ng1975 |
0.341 |
|
| 2006 |
Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ. Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene. 25: 6128-32. PMID 16652146 DOI: 10.1038/Sj.Onc.1209627 |
0.749 |
|
| 2006 |
Chute JP, Taylor E, Williams J, Kaye F, Venzon D, Johnson BE. A metabolic study of patients with lung cancer and hyponatremia of malignancy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 888-96. PMID 16467103 DOI: 10.1158/1078-0432.Ccr-05-1536 |
0.322 |
|
| 2005 |
Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes Cancer Research. 65: 7137-7144. PMID 16103063 DOI: 10.1158/0008-5472.Can-05-1125 |
0.76 |
|
| 2004 |
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (New York, N.Y.). 304: 1497-500. PMID 15118125 DOI: 10.1126/Science.1099314 |
0.304 |
|
| 2004 |
Rahman L, Voeller D, Rahman M, Lipkowitz S, Allegra C, Barrett JC, Kaye FJ, Zajac-Kaye M. Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell. 5: 341-51. PMID 15093541 DOI: 10.1016/S1535-6108(04)00080-7 |
0.344 |
|
| 2003 |
Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nature Genetics. 33: 208-13. PMID 12539049 DOI: 10.1038/Ng1083 |
0.745 |
|
| 2002 |
Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene. 21: 6908-14. PMID 12362273 DOI: 10.1038/sj.onc.1205834 |
0.383 |
|
| 2000 |
Modi S, Kubo A, Oie H, Coxon AB, Rehmatulla A, Kaye FJ. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Oncogene. 19: 4632-9. PMID 11030152 DOI: 10.1038/Sj.Onc.1203815 |
0.767 |
|
| 2000 |
Kaye FJ, Modi S, Ivanovska I, Koonin EV, Thress K, Kubo A, Kornbluth S, Rose MD. A family of ubiquitin-like proteins binds the ATPase domain of Hsp70-like Stch. Febs Letters. 467: 348-55. PMID 10675567 DOI: 10.1016/S0014-5793(00)01135-2 |
0.328 |
|
| 2000 |
ZAJAC-KAYE M, BEN-BARUCH N, KASTANOS E, KAYE FJ, ALLEGRA C. Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells Biochemical Journal. 345: 535-541. DOI: 10.1042/BJ3450535 |
0.302 |
|
| 1999 |
Otterson GA, Modi S, Nguyen K, Coxon AB, Kaye FJ. Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families. American Journal of Human Genetics. 65: 1040-6. PMID 10486322 DOI: 10.1086/302581 |
0.753 |
|
| 1999 |
Chen WD, Geradts J, Keane MM, Lipkowitz S, Zajac-Kaye M, Kaye FJ. The 100-kDa proteolytic fragment of RB is retained predominantly within the nuclear compartment of apoptotic cells Molecular Cell Biology Research Communications. 1: 216-220. PMID 10425229 DOI: 10.1006/MCBR.1999.0132 |
0.319 |
|
| 1998 |
Coxon AB, Ward JM, Geradts J, Otterson GA, Zajac-Kaye M, Kaye FJ. RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer. Oncogene. 17: 1625-8. PMID 9794240 DOI: 10.1038/Sj.Onc.1202381 |
0.748 |
|
| 1998 |
Otterson GA, Xiao GH, Geradts J, Jin F, Chen WD, Niklinska W, Kaye FJ, Yeung RS. Protein expression and functional analysis of the FHIT gene in human tumor cells Journal of the National Cancer Institute. 90: 426-432. PMID 9521166 DOI: 10.1093/JNCI/90.6.426 |
0.399 |
|
| 1998 |
Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WG. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes & Development. 12: 95-106. PMID 9420334 DOI: 10.1101/Gad.12.1.95 |
0.396 |
|
| 1997 |
Otterson GA, Chen Wd, Coxon AB, Khleif SN, Kaye FJ. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proceedings of the National Academy of Sciences of the United States of America. 94: 12036-40. PMID 9342358 DOI: 10.1073/Pnas.94.22.12036 |
0.767 |
|
| 1997 |
Chen WD, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ. Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene. 14: 1243-8. PMID 9121775 DOI: 10.1038/Sj.Onc.1201096 |
0.711 |
|
| 1996 |
Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proceedings of the National Academy of Sciences of the United States of America. 93: 4350-4. PMID 8633069 DOI: 10.1073/Pnas.93.9.4350 |
0.312 |
|
| 1995 |
Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene. 11: 1211-6. PMID 7566983 |
0.757 |
|
| 1995 |
Kratzke RA, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J, Kaye FJ. Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. Journal of the National Cancer Institute. 87: 1870-5. PMID 7494231 DOI: 10.1093/JNCI/87.24.1870 |
0.374 |
|
| 1994 |
Kratzke RA, Otterson GA, Hogg A, Coxon AB, Geradts J, Cowell JK, Kaye FJ. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene. 9: 1321-6. PMID 8152792 |
0.747 |
|
| 1994 |
Kim YW, Otterson GA, Kratzke RA, Coxon AB, Kaye FJ. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein. Molecular and Cellular Biology. 14: 7256-64. PMID 7935440 DOI: 10.1128/Mcb.14.11.7256 |
0.723 |
|
| 1994 |
Otterson G, Flynn G, Kratzke R, Coxon A, Johnston P, Kaye F. Stch encodes the ‘ATPase core’ of a microsomal stress 70 protein. The Embo Journal. 13: 1216-1225. DOI: 10.1002/J.1460-2075.1994.Tb06371.X |
0.711 |
|
| 1992 |
Kratzke RA, Shimizu E, Kaye FJ. Oncogenes in human lung cancer. Cancer Treatment and Research. 63: 61-85. PMID 1363367 DOI: 10.1007/978-1-4615-3088-6_3 |
0.371 |
|
| 1992 |
Kim J, Kaye FJ, Henslee JG, Shively JE, Park JG, Lai SL, Linnoila RI, Mulshine JL, Gazdar AF. Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. International Journal of Cancer. 52: 718-25. PMID 1330929 DOI: 10.1002/Ijc.2910520509 |
0.329 |
|
| 1991 |
Kaelin WG, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM. Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product Cell. 64: 521-532. PMID 1825028 DOI: 10.1016/0092-8674(91)90236-R |
0.346 |
|
| 1990 |
Horowitz JM, Park SH, Bogenmann E, Cheng JC, Yandell DW, Kaye FJ, Minna JD, Dryja TP, Weinberg RA. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells Proceedings of the National Academy of Sciences of the United States of America. 87: 2775-2779. PMID 2181449 DOI: 10.1073/Pnas.87.7.2775 |
0.375 |
|
| 1990 |
Kaye FJ, Kratzke RA, Gerster JL, Lin PS. Recessive oncogenes in lung cancer American Review of Respiratory Disease. 142. PMID 2174662 DOI: 10.1164/AJRCCM/142.6_PT_2.S44 |
0.348 |
|
| 1990 |
Kaye FJ, Kratzke RA, Gerster JL, Horowitz JM. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding Proceedings of the National Academy of Sciences of the United States of America. 87: 6922-6926. PMID 2168563 DOI: 10.1073/PNAS.87.17.6922 |
0.361 |
|
| 1988 |
Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC Science. 241: 353-357. PMID 2838909 DOI: 10.1126/SCIENCE.2838909 |
0.357 |
|
| Show low-probability matches. |